1
|
Yamaguchi A, Stanger L, Freedman CJ, Standley M, Hoang T, Reheman A, Wan-Chen T, van Hoorebeke C, Holman TR, Holinstat M. DHA 12-LOX-derived oxylipins regulate platelet activation and thrombus formation through a PKA-dependent signaling pathway. J Thromb Haemost 2021; 19:839-851. [PMID: 33222370 PMCID: PMC7925359 DOI: 10.1111/jth.15184] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2020] [Revised: 10/28/2020] [Accepted: 11/16/2020] [Indexed: 12/16/2022]
Abstract
BACKGROUND The effects of docosahexaenoic acid (DHA) on cardiovascular disease are controversial and a mechanistic understanding of how this omega-3 polyunsaturated fatty acid (ω-3 PUFA) regulates platelet reactivity and the subsequent risk of a thrombotic event is warranted. In platelets, DHA is oxidized by 12-lipoxygenase (12-LOX) producing the oxidized lipids (oxylipins) 11-HDHA and 14-HDHA. We hypothesized that 12-LOX DHA-oxylipins may be involved in the beneficial effects observed in dietary supplemental treatment with ω-3 PUFAs or DHA itself. OBJECTIVES To determine the effects of DHA, 11-HDHA, and 14-HDHA on platelet function and thrombus formation, and to elucidate the mechanism by which these ω-3 PUFAs regulate platelet activation. METHODS AND RESULTS DHA, 11-HDHA, and 14-HDHA attenuated collagen-induced human platelet aggregation, but only the oxylipins inhibited ⍺IIbβ3 activation and decreased ⍺-granule secretion. Furthermore, treatment of whole blood with DHA and its oxylipins impaired platelet adhesion and accumulation to a collagen-coated surface. Interestingly, thrombus formation was only diminished in mice treated with 11-HDHA or 14-HDHA, and mouse platelet activation was inhibited following acute treatment with these oxylipins or chronic treatment with DHA, suggesting that under physiologic conditions, the effects of DHA are mediated through its oxylipins. Finally, the protective mechanism of DHA oxylipins was shown to be mediated via activation of protein kinase A. CONCLUSIONS This study provides the first mechanistic evidence of how DHA and its 12-LOX oxylipins inhibit platelet activity and thrombus formation. These findings support the beneficial effects of DHA as therapeutic intervention in atherothrombotic diseases.
Collapse
Affiliation(s)
- Adriana Yamaguchi
- Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI
| | - Livia Stanger
- Department of Biology, Colby College, Waterville, ME
| | - Cody J Freedman
- Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA
| | - Melissa Standley
- Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA
| | - Timothy Hoang
- Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI
| | - Adili Reheman
- Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI
| | - Tsai Wan-Chen
- Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA
| | | | - Theodore R. Holman
- Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA
| | - Michael Holinstat
- Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI
- Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Medical School, Ann Arbor, MI
| |
Collapse
|
2
|
Au NT, Reyes M, Boyer BB, Hopkins SE, Black J, O’Brien D, Fohner AE, Yracheta J, Thornton T, Austin MA, Burke W, Thummel KE, Rettie AE. Dietary and genetic influences on hemostasis in a Yup'ik Alaska Native population. PLoS One 2017; 12:e0173616. [PMID: 28376131 PMCID: PMC5380313 DOI: 10.1371/journal.pone.0173616] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2016] [Accepted: 02/23/2017] [Indexed: 11/23/2022] Open
Abstract
Fish and marine animals are important components of the subsistence diet of Alaska Native people, resulting in a high ω3 PUFA intake. The historical record for circumpolar populations highlights a tendency for facile bleeding, possibly related to ω3 PUFA effects on platelet activation and/or vitamin K-dependent clotting factors. To evaluate these two scenarios in Yup'ik people of southwestern Alaska, we examined the association between dietary ω3 PUFA intake and activities of clotting factor II, V, fibrinogen, PT, INR, PTT, and sP-selectin in 733 study participants, using the nitrogen isotope ratio of red blood cells as a biomarker of ω3 PUFA consumption. sP-selectin alone correlated strongly and inversely with ω3 PUFA consumption. Approximately 36% of study participants exhibited PIVKA-II values above the threshold of 2 ng/ml, indicative of low vitamin K status. To assess genetic influences on vitamin K status, study participants were genotyped for common vitamin K cycle polymorphisms in VKORC1, GGCX and CYP4F2. Only CYP4F2*3 associated significantly with vitamin K status, for both acute (plasma vitamin K) and long-term (PIVKA-II) measures. These findings suggest: (i) a primary association of ω3 PUFAs on platelet activation, as opposed to vitamin K-dependent clotting factor activity, (ii) that reduced CYP4F2 enzyme activity associates with vitamin K status. We conclude that high ω3 PUFA intake promotes an anti-platelet effect and speculate that the high frequency of the CYP4F2*3 allele in Yup'ik people (~45%) evolved in response to a need to conserve body stores of vitamin K due to environmental limitations on its availability.
Collapse
Affiliation(s)
- Nicholas T. Au
- Department of Medicinal Chemistry, University of Washington, Seattle, Washington, United States of America
| | - Morayma Reyes
- Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America
| | - Bert B. Boyer
- Center for Alaska Native Health Research, University of Alaska Fairbanks, Fairbanks, Alaska, United States of America
| | - Scarlett E. Hopkins
- Center for Alaska Native Health Research, University of Alaska Fairbanks, Fairbanks, Alaska, United States of America
| | - Jynene Black
- Center for Alaska Native Health Research, University of Alaska Fairbanks, Fairbanks, Alaska, United States of America
| | - Diane O’Brien
- Center for Alaska Native Health Research, University of Alaska Fairbanks, Fairbanks, Alaska, United States of America
| | - Alison E. Fohner
- Public Health Genetics, University of Washington, Seattle, Washington, United States of America
| | - Joe Yracheta
- Department of Pharmaceutics, University of Washington, Seattle, Washington, United States of America
| | - Timothy Thornton
- Department of Biostatistics, University of Washington, Seattle, Washington, United States of America
| | - Melissa A. Austin
- Department of Epidemiology, University of Washington, Seattle, Washington, United States of America
| | - Wylie Burke
- Department of Medical Ethics, University of Washington, Seattle, Washington, United States of America
| | - Kenneth E. Thummel
- Department of Pharmaceutics, University of Washington, Seattle, Washington, United States of America
| | - Allan E. Rettie
- Department of Medicinal Chemistry, University of Washington, Seattle, Washington, United States of America
| |
Collapse
|
3
|
Piccione G, Marafioti S, Giannetto C, Panzera M, Fazio F. Effect of dietary supplementation with omega 3 on clotting time, fibrinogen concentration and platelet aggregation in the athletic horse. Livest Sci 2014. [DOI: 10.1016/j.livsci.2013.12.032] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
4
|
Lu Y, Boekschoten MV, Wopereis S, Müller M, Kersten S. Comparative transcriptomic and metabolomic analysis of fenofibrate and fish oil treatments in mice. Physiol Genomics 2011; 43:1307-18. [DOI: 10.1152/physiolgenomics.00100.2011] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Elevated circulating triglycerides, which are considered a risk factor for cardiovascular disease, can be targeted by treatment with fenofibrate or fish oil. To gain insight into underlying mechanisms, we carried out a comparative transcriptomics and metabolomics analysis of the effect of 2 wk treatment with fenofibrate and fish oil in mice. Plasma triglycerides were significantly decreased by fenofibrate (−49.1%) and fish oil (−21.8%), whereas plasma cholesterol was increased by fenofibrate (+29.9%) and decreased by fish oil (−32.8%). Levels of various phospholipid species were specifically decreased by fish oil, while levels of Krebs cycle intermediates were increased specifically by fenofibrate. Plasma levels of many amino acids were altered by fenofibrate and to a lesser extent by fish oil. Both fenofibrate and fish oil upregulated genes involved in fatty acid metabolism and downregulated genes involved in blood coagulation and fibrinolysis. Significant overlap in gene regulation by fenofibrate and fish oil was observed, reflecting their property as high or low affinity agonist for peroxisome proliferator-activated receptor-α, respectively. Fenofibrate specifically downregulated genes involved in complement cascade and inflammatory response. Fish oil specifically downregulated genes involved in cholesterol and fatty acid biosynthesis and upregulated genes involved in amino acid and arachidonic acid metabolism. Taken together, the data indicate that despite being similarly potent toward modulating plasma free fatty acids, cholesterol, and triglyceride levels, fish oil causes modest changes in gene expression likely via activation of multiple mechanistic pathways, whereas fenofibrate causes pronounced gene expression changes via a single pathway, reflecting the key difference between nutritional and pharmacological intervention.
Collapse
Affiliation(s)
- Yingchang Lu
- Nutrition, Metabolism and Genomics group, Division of Human Nutrition, Wageningen University, Wageningen
- National Institute for Public Health and the Environment, Bilthoven
| | - Mark V. Boekschoten
- Nutrition, Metabolism and Genomics group, Division of Human Nutrition, Wageningen University, Wageningen
- The Netherlands Nutrigenomics Centre, TI Food and Nutrition, Wageningen; and
| | - Suzan Wopereis
- The Netherlands Nutrigenomics Centre, TI Food and Nutrition, Wageningen; and
- TNO Innovation for life, Earth, Environmental and Life Sciences, Zeist, the Netherlands
| | - Michael Müller
- Nutrition, Metabolism and Genomics group, Division of Human Nutrition, Wageningen University, Wageningen
- The Netherlands Nutrigenomics Centre, TI Food and Nutrition, Wageningen; and
| | - Sander Kersten
- Nutrition, Metabolism and Genomics group, Division of Human Nutrition, Wageningen University, Wageningen
- The Netherlands Nutrigenomics Centre, TI Food and Nutrition, Wageningen; and
| |
Collapse
|
5
|
Vanschoonbeek K, Wouters K, van der Meijden PE, van Gorp PJ, Feijge MA, Herfs M, Schurgers LJ, Hofker MH, de Maat MP, Heemskerk JW. Anticoagulant Effect of Dietary Fish Oil in Hyperlipidemia. Arterioscler Thromb Vasc Biol 2008; 28:2023-9. [DOI: 10.1161/atvbaha.107.156992] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Objective—
In hyperlipidemia, dietary fish oil containing n-3 polyunsaturated fatty acids (PUFA) provokes plasma triacylglycerol lowering and hypocoagulant activity. Using APOE2 knock-in mice, the relation of these fish-oil effects with altered gene expression was investigated.
Methods and Results—
Male APOE2 knock-in mice, fed regular low-fat diet, had elevated plasma levels of triacylglycerol and coagulation factors. Plasma lipids and (anti)coagulant factors reduced on feeding the mice with fish oil (n-3 PUFA) or, to a lesser degree, with sunflowerseed oil (n-6 PUFA). The fish-oil diet provoked a 40% reduction in thrombin generation. Microarray (Affymetrix) and single-gene expression analysis of mouse livers showed that fish oil induced: (1) upregulation of genes contributing to lipid degradation and oxidation; (2) downregulation of genes of γ-glutamyl carboxylase and of transcription factors implicated in lipid synthesis; (3) unchanged expression of coagulation factor genes. After fish-oil diet, vitamin K–dependent coagulation factors accumulated in periportal areas of the liver; prothrombin was partly retained in uncarboxylated form. Only part of the changes in gene expression were different from the effects of sunflowerseed oil diet.
Conclusions—
The hypocoagulant effect of n-3 PUFA is not caused by reduced hepatic synthesis of coagulation factors, but rather results from retention of uncarboxylated coagulation factors. In contrast, the lipid-lowering effect of n-3 PUFA links to altered expression of genes that regulate transcription and fatty acid metabolism.
Collapse
Affiliation(s)
- Kristof Vanschoonbeek
- From the Departments of Biochemistry (K.V., P.E.J.v.M., M.A.H.F., L.J.S., J.W.M.H.), Human Biology (K.V.), and Molecular Genetics (K.W., P.J.v.G., M.H.H.), CARIM and NUTRIM, and VitaK (M.H., L.J.S.), Maastricht University, The Netherlands; the Department of Pathology and Laboratory Medicine (M.H.H.), University Medical Center Groningen, The Netherlands; and the Department of Hematology (M.d.M.), Erasmus Medical Centre Rotterdam, The Netherlands
| | - Kristiaan Wouters
- From the Departments of Biochemistry (K.V., P.E.J.v.M., M.A.H.F., L.J.S., J.W.M.H.), Human Biology (K.V.), and Molecular Genetics (K.W., P.J.v.G., M.H.H.), CARIM and NUTRIM, and VitaK (M.H., L.J.S.), Maastricht University, The Netherlands; the Department of Pathology and Laboratory Medicine (M.H.H.), University Medical Center Groningen, The Netherlands; and the Department of Hematology (M.d.M.), Erasmus Medical Centre Rotterdam, The Netherlands
| | - Paola E.J. van der Meijden
- From the Departments of Biochemistry (K.V., P.E.J.v.M., M.A.H.F., L.J.S., J.W.M.H.), Human Biology (K.V.), and Molecular Genetics (K.W., P.J.v.G., M.H.H.), CARIM and NUTRIM, and VitaK (M.H., L.J.S.), Maastricht University, The Netherlands; the Department of Pathology and Laboratory Medicine (M.H.H.), University Medical Center Groningen, The Netherlands; and the Department of Hematology (M.d.M.), Erasmus Medical Centre Rotterdam, The Netherlands
| | - Patrick J. van Gorp
- From the Departments of Biochemistry (K.V., P.E.J.v.M., M.A.H.F., L.J.S., J.W.M.H.), Human Biology (K.V.), and Molecular Genetics (K.W., P.J.v.G., M.H.H.), CARIM and NUTRIM, and VitaK (M.H., L.J.S.), Maastricht University, The Netherlands; the Department of Pathology and Laboratory Medicine (M.H.H.), University Medical Center Groningen, The Netherlands; and the Department of Hematology (M.d.M.), Erasmus Medical Centre Rotterdam, The Netherlands
| | - Marion A.H. Feijge
- From the Departments of Biochemistry (K.V., P.E.J.v.M., M.A.H.F., L.J.S., J.W.M.H.), Human Biology (K.V.), and Molecular Genetics (K.W., P.J.v.G., M.H.H.), CARIM and NUTRIM, and VitaK (M.H., L.J.S.), Maastricht University, The Netherlands; the Department of Pathology and Laboratory Medicine (M.H.H.), University Medical Center Groningen, The Netherlands; and the Department of Hematology (M.d.M.), Erasmus Medical Centre Rotterdam, The Netherlands
| | - Marjolein Herfs
- From the Departments of Biochemistry (K.V., P.E.J.v.M., M.A.H.F., L.J.S., J.W.M.H.), Human Biology (K.V.), and Molecular Genetics (K.W., P.J.v.G., M.H.H.), CARIM and NUTRIM, and VitaK (M.H., L.J.S.), Maastricht University, The Netherlands; the Department of Pathology and Laboratory Medicine (M.H.H.), University Medical Center Groningen, The Netherlands; and the Department of Hematology (M.d.M.), Erasmus Medical Centre Rotterdam, The Netherlands
| | - Leon J. Schurgers
- From the Departments of Biochemistry (K.V., P.E.J.v.M., M.A.H.F., L.J.S., J.W.M.H.), Human Biology (K.V.), and Molecular Genetics (K.W., P.J.v.G., M.H.H.), CARIM and NUTRIM, and VitaK (M.H., L.J.S.), Maastricht University, The Netherlands; the Department of Pathology and Laboratory Medicine (M.H.H.), University Medical Center Groningen, The Netherlands; and the Department of Hematology (M.d.M.), Erasmus Medical Centre Rotterdam, The Netherlands
| | - Marten H. Hofker
- From the Departments of Biochemistry (K.V., P.E.J.v.M., M.A.H.F., L.J.S., J.W.M.H.), Human Biology (K.V.), and Molecular Genetics (K.W., P.J.v.G., M.H.H.), CARIM and NUTRIM, and VitaK (M.H., L.J.S.), Maastricht University, The Netherlands; the Department of Pathology and Laboratory Medicine (M.H.H.), University Medical Center Groningen, The Netherlands; and the Department of Hematology (M.d.M.), Erasmus Medical Centre Rotterdam, The Netherlands
| | - Moniek P.M. de Maat
- From the Departments of Biochemistry (K.V., P.E.J.v.M., M.A.H.F., L.J.S., J.W.M.H.), Human Biology (K.V.), and Molecular Genetics (K.W., P.J.v.G., M.H.H.), CARIM and NUTRIM, and VitaK (M.H., L.J.S.), Maastricht University, The Netherlands; the Department of Pathology and Laboratory Medicine (M.H.H.), University Medical Center Groningen, The Netherlands; and the Department of Hematology (M.d.M.), Erasmus Medical Centre Rotterdam, The Netherlands
| | - Johan W.M. Heemskerk
- From the Departments of Biochemistry (K.V., P.E.J.v.M., M.A.H.F., L.J.S., J.W.M.H.), Human Biology (K.V.), and Molecular Genetics (K.W., P.J.v.G., M.H.H.), CARIM and NUTRIM, and VitaK (M.H., L.J.S.), Maastricht University, The Netherlands; the Department of Pathology and Laboratory Medicine (M.H.H.), University Medical Center Groningen, The Netherlands; and the Department of Hematology (M.d.M.), Erasmus Medical Centre Rotterdam, The Netherlands
| |
Collapse
|
6
|
Poulsen RC, Moughan PJ, Kruger MC. Docosahexaenoic acid and 17 beta-estradiol co-treatment is more effective than 17 beta-estradiol alone in maintaining bone post-ovariectomy. Exp Biol Med (Maywood) 2008; 233:592-602. [PMID: 18375826 DOI: 10.3181/0709-rm-259] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Bone-protective effects of combined treatment with long chain polyunsaturated fatty acids (LCPUFAs) and estrogenic compounds following ovariectomy have previously been reported. Recent evidence suggests the n-3 LCPUFA docosahexaenoic acid (DHA, 22:6n-3) is particularly bone-protective. The aim of this study was to determine whether combined treatment with DHA and estrogenic compounds has a beneficial effect on bone mass in ovariectomized (OVX) rats. Rats were randomized into 9 groups and either ovariectomized (8 groups) or sham-operated (1 group). Using a 2 x 4 factorial design approach, OVX animals received either no estrogenic compound, genistein (20 mg/kg body weight/day), daidzein, (20 mg/kg body weight/day) or 17 beta-estradiol (1 microg/day) with or without DHA (0.5 g/kg body weight/day) for 18 weeks. Bone mineral content (BMC), area (BA), and density (BMD), plasma osteocalcin and IL-6 concentrations, and red blood cell (RBC) fatty acid composition were measured. Femur BMC was significantly greater in animals treated with DHA or 17 beta-estradiol than in ovariectomized controls. Plasma carboxylated osteocalcin was significantly higher in DHA-treated animals and total osteocalcin significantly lower in 17 beta-estradiol-treated animals compared with ovariectomized controls. There were significant interactions between treatment with estrogenic compounds and DHA for femur BMC, plasma IL-6 concentration, and RBC fatty acid composition. Combined treatment with 17beta-estradiol+DHA was more effective than either treatment alone at preserving femur BMC and lowering circulating concentrations of pro-inflammatory IL-6. The percentage of n-3 LCPUFAs in RBCs was significantly greater in animals receiving 17 beta-estradiol+DHA compared with either treatment alone. There was no beneficial effect of combined DHA and phytoestrogen treatment on bone. Results from this study raise the possibility that co-treatment with 17 beta-estradiol and DHA may allow a lower dose of 17 beta-estradiol to be used to provide the same bone-protective effects as when 17 beta-estradiol is administered alone.
Collapse
Affiliation(s)
- Raewyn C Poulsen
- Institute of Food, Nutrition and Human Health, Massey University, Private Bag 11-222, Palmerston North 4442, New Zealand
| | | | | |
Collapse
|
7
|
Abstract
OBJECTIVES The possible link between folic acid or folate and tetrahydrobiopterin (H(4)B), vitamin C, polyunsaturated fatty acids (PUFAs), and nitric oxide (NO), which may explain the beneficial actions of these nutrients in various vascular conditions, was investigated. METHODS The literature pertaining to the actions of folic acid/folate, H(4)B, vitamin C, PUFAs, and NO was reviewed. RESULTS Impaired endothelial NO (eNO) activity is an early marker for cardiovascular disease. Most risk factors for atherosclerosis are associated with impaired endothelium-dependent vasodilatation due to reduced NO production. Folate not only reduces plasma homocysteine levels but also enhances eNO synthesis and shows anti-inflammatory actions. It stimulates endogenous H(4)B regeneration, a cofactor necessary for eNO synthesis, inhibits intracellular superoxide generation, and thus enhances the half-life of NO. H(4)B in turn enhances NO generation and augments arginine transport into the cells. Folic acid increases the concentration of omega-3 PUFAs, which also enhance eNO synthesis. Vitamin C augments eNO synthesis by increasing intracellular H(4)B and stabilization of H(4)B. Insulin stimulates H(4)B synthesis and PUFA metabolism, suppresses the production of proinflammatory cytokine tumor necrosis factor-alpha and superoxide anion, and enhances NO generation. The ability of folate to augment eNO generation is independent of its capacity to lower plasma homocysteine levels. CONCLUSIONS The common mechanism by which folic acid, H(4)B, vitamin C, omega-3 fatty acids, and L-arginine bring about their beneficial actions in various vascular diseases is by enhancing eNO production. Hence, it remains to be determined whether a judicious combination of folic acid, vitamins B12, B6, and C, H(4)B, L-arginine, and omega-3 fatty acids in appropriate amounts may form a novel approach in the prevention and management of various conditions such as hyperlipidemias, coronary heart disease, atherosclerosis, peripheral vascular disease, and some neurodegenerative conditions.
Collapse
|
8
|
Quéré I, Perneger TV, Zittoun J, Bellet H, Gris JC, Daurès JP, Schved JF, Mercier E, Laroche JP, Dauzat M, Bounameaux H, Janbon C, de Moerloose P. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study. Lancet 2002; 359:747-52. [PMID: 11888585 DOI: 10.1016/s0140-6736(02)07876-5] [Citation(s) in RCA: 72] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
BACKGROUND Moderate hyperhomocysteinaemia is a risk factor for venous thromboembolism. We do not know whether this risk depends on homocysteine itself or on components of the homocysteine remethylation pathway, such as methylfolate. We did a case-control study to analyse the relation between the major components of the homocysteine remethylation pathway and risk of venous thromboembolism. METHODS We measured concentrations of homocysteine, methionine, and folate in plasma, total folate and methylfolate in red-blood cells, and 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T genotype and other known risk factors for venous thromboembolic disease in 243 patients with deep vein thrombosis or pulmonary embolism and controls matched for sex and age. FINDINGS Concentrations in plasma of homocysteine differed significantly between cases and controls. We noted a strong concentration-dependent association between concentrations of methylfolate in red-blood cells and risk of venous thromboembolism. The adjusted conditional odds ratio ranged from 1.0 for methylfolate 249 microg/L or greater to 7.1 (3.2-15.8) for methylfolate 141 microg/L or less. Methionine concentrations below the median were also independently associated with raised risk of venous thromboembolic disease, as were established risk factors such as high body-mass index, history of cancer, family history of thromboembolism, oral contraceptive use, and factor V Leiden mutation. Furthermore, the association between concentrations of methylfolate in red-blood cells and risk of thromboembolism varied according to MTHFR C677T genotype. INTERPRETATION Measurement of methylfolate concentrations in red-blood cells might help to identify people at risk of venous thromboembolism.
Collapse
Affiliation(s)
- Isabelle Quéré
- Internal Medicine Department University Hospital Saint Eloi, Montpellier, France.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Leray C, Wiesel ML, Freund M, Cazenave JP, Gachet C. Long-chain n-3 fatty acids specifically affect rat coagulation factors dependent on vitamin K: relation to peroxidative stress. Arterioscler Thromb Vasc Biol 2001; 21:459-65. [PMID: 11231929 DOI: 10.1161/01.atv.21.3.459] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Fatty acids of marine origin have been shown to affect blood coagulation in the rat. In an attempt to gain insight into the mechanisms of this phenomenon, we studied the effects of dietary linseed and fish oils on the liver antioxidant status and plasma coagulation parameters in rats on a time-course basis. Dietary enrichment in eicosapentaenoic and docosahexaenoic acids resulted in strong hypocoagulation after only 1 week and a concomitant increase in liver lipid peroxidation and tocopherolquinone content. Enrichment in linolenic acid induced similar increases in lipid peroxidation and tocopherol catabolism but negligible alteration of coagulation. A significant correlation between plasma factor II coagulant activity and liver tocopherolquinone was found in fish oil- but not in linseed oil-fed rats. Although ingestion of tocopherolquinone led to high levels of this compound in the liver, it had only marginal effects on coagulation factors. Thus, it seems unlikely that this vitamin E metabolite could be involved in the lowering of vitamin K-dependent clotting factors through inhibition of gamma-glutamylcarboxylase. Rather, our results indicate that the effects of the n-3 fatty acids of fish oil on vitamin K-dependent coagulation factors are specific and independent of liver tocopherolquinone levels.
Collapse
Affiliation(s)
- C Leray
- INSERM U.311, Etablissement Français du Sang-Alsace, Strasbourg, France.
| | | | | | | | | |
Collapse
|
10
|
Andriamampandry MD, Leray C, Freund M, Cazenave JP, Gachet C. Antithrombotic effects of (n-3) polyunsaturated fatty acids in rat models of arterial and venous thrombosis. Thromb Res 1999; 93:9-16. [PMID: 10065894 DOI: 10.1016/s0049-3848(98)00149-2] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
The antithrombotic effects of dietary lipids were investigated in rat models of arterial and venous thrombosis. In the arterial model, thrombus formation was evaluated by determination of the occlusion time and the deposition of 111In-labeled platelets and 125I-labeled fibrinogen in a collagen-coated glass capillary inserted into an arterio-arterial shunt. Venous thrombosis was evaluated by measurement of the thrombus weight after administration of thromboplastin as a source of tissue factor and establishment of stasis in the vena cava. Diets were supplemented with saturated (SAT group) or (n-3) fatty acids, the latter being added either as MaxEPA oil (MaxEPA group), or as docosahexaenoic (DHA group) or eicosapentaenoic (EPA group) ethyl ester. Only the MaxEPA group displayed a prolonged occlusion time as compared with all other groups. Platelet accumulation, similar in the MaxEPA, EPA and DHA groups (13.3, 16.7 and 17.7 x 10(6) platelets/shunt, respectively), was significantly higher in the SAT group (25.3 x 10(6) platelets/shunt), while accumulation of fibrinogen-fibrin was similar whatever the group. There was a trend towards a lower venous thrombus weight in MaxEPA fed rats relative to those fed other diets. Our data indicate that the MaxEPA diet had antithrombotic effects in arterial and to a lesser extent venous thrombosis models, best attributed to its multiple targeting of platelets and coagulation.
Collapse
|